Feature Story On Shycocan From Mumbai

The corona virus resistant device is the psychican

COVID-19 heightened the threat of viruses in real life: Alok Sharma

Shycocan’s virus attenuation device claims to disable coronavirus and its variants: What it is? How it works?

Shycocan – A Gift for Someone You Care

Noida factory with 600+ Staff Installs Unique Virus Attenuation Devices to Curb Coronavirus

How polluted indoor air causes respiratory infections

Shycocan | Indian Express Article – Understanding the truth

Ingram Micro signs agreement with Shycocan to distribute Virus Attenuation Device

Indian-built device to contain Covid infectivity gets US, EU nod

Corona Cannon: This Made-in-India device can neutralise coronavirus, make public places safer

Device to prevent Coronavirus! USFDA clears Shycocan which neutralises 99.9% virus floating in closed spaces

Shycocan, World’s First Virus Attenuation Device Developed in India, Gets Businesses Back on Track in Pandemic Times

Shycocan is giving a relief in this pandemic time

The corona virus resistant device is the psychican

Shycocan is one-of-a-kind virus neutralisation device ready for future pandemics

Shycocan Named Official Safety Partner For The India Pavilion At Expo 2020 Dubai

Indian-made Device That Can ‘neutralise Covid’ Gets US FDA & EU Nod; It’s Called Shycocan

New device to combat Covid-19

Bengaluru Organisation Gets US FDA, EU Nod For Device That Can Kill COVID-19 Virus

Made In India: World’s first virus attenuation device now in Kolkata

Bengaluru Organisation Gets US FDA, EU Approval For Medical Device That Can Neutralise Coronavirus

There is a growing demand for Shycocan device in Kolkata: Shycocan Corporation CEO

Shycocan A Virus Attenuation Device Developed in India

Demand for coronavirus disabling device strong across markets: Shycocan Corp

Disable the Coronavirus and Influenza virus families in indoor spaces with 99.994% efficacy

Bengaluru scientist develops device to disable coronavirus

Aajkaal is a Bengali newspaper in Kolkata, India. Aajkaal is simultaneously published from Kolkata, Siliguri, and its Tripura edition is published from Agartala. The newspaper was started in 1981.

Shycocan strides towards neutralising Coronavirus

Shycocan to invest around Rs. 100 crore over next three years for future growth

Vaccine plus technology: What we need to combat Covid 2.0 – Dr. Ajai Chowdhry

Coronavirus-busting device to be manufactured in India from Sept

SHYCOCAN — a canon to kill coronavirus manufactured in Bengaluru — Here’s how it works

SHYCOCAN – A Device to Disable Coronaviruses – to be Marketed Under US-FDA’s Enforcement Discretion During the COVID-19 Public Health Emergency

Meet the innovator who claims his device can kill the coronavirus

Shycocan, virus attenuation device launched at UAE’s ICPM Healthcare Conference & Exhibition

Virus Attenuation In Companies To Protect Against Corona – Noida News

Agility, innovation, safety key to success in post-pandemic era

Shycocan | Facts vs. Misrepresentation in Media | The Wire

Now, a device to kill coronavirus? Bengaluru firm gets US FDA, EU nod

Bengaluru-based firm comes up with device that can kill coronavirus, to be manufactured and marketed in US, EU

This Made In India Device Claims To Help Curb Spread Of COVID-19 In Indoor Spaces


Shycocan Developers Hold a Webinar to Showcase its Device


Shycocan Corporation Icon

Enterprise grade build with superior components and longer durability

Shycocan Corporation Icon

1 year On-site replacement Warranty in major cities.

Shycocan Icon

Professional services designed for enterprises, on request

At Shycocan, we welcome the opportunity to speak with potential partners, customers, or anyone with an interest in learning more about the transformative potential of our technology.


Shycocan Corporation is in the business of manufacturing, sales, marketing, and distribution of the Shycocan Virus Attenuation Device (‘Shycocan VAD’), a device that disables up to 99.9% of certain classes of viruses, only if the device is installed, operated and maintained as prescribed and under pre-defined conditions. The device is tested for its efficacy and safety and is proven in multiple virology laboratory tests from accredited laboratories. Shycocan Corporation, its parent entity and its associates, subsidiaries, joint venture companies, and their respective promoters, shareholders, directors, management, managers, employees, distributors and channel partners and agencies shall bear no liability personally, individually, jointly or severally to any person or persons using the Shycocan VAD, or to any person or persons who the users of Shycocan VAD intend to protect, and they shall bear no liability whatsoever to any person whomsoever who may catch any infection at any place prior to or after leaving those areas where the Shycocan VAD is installed and operational. All the content in our marketing materials and on our website is intended solely for informational purpose only and is not intended to be used as medical suggestion or healthcare advice. Further, it is provided on an “as is” and “as available” basis. Except as specifically provided herein, to the fullest extent permissible pursuant to applicable law, Shycocan Corporation expressly disclaims all warranties of any kind, whether express, legal or implied, including, without limitation, any warranties of merchantability, fitness for a particular purpose and non-infringement. Shycocan Corporation is committed to keeping its customers safe, protected and to help bring business back to business, and life back to normal, but our customers are requested to take all precautions prescribed by the government health authorities in their respective countries to ensure that they and their customers, employees, visitors and families remain safe. Shycocan VAD shall be used in addition to and not in substitution of prevention guidelines issued by appropriate government healthcare authorities and WHO.